Trial Profile
Dose escalation safety study of MM-10-001 [lentinan]
Status:
Active, no longer recruiting
Phase of Trial:
Phase I
Latest Information Update: 09 Nov 2021
Price :
$35
*
At a glance
- Drugs Lentinan (Primary)
- Indications Lung cancer
- Focus Adverse reactions
- Sponsors GlycaNova
- 05 Jun 2008 New trial record.